MedPath

Purified Cortrophin Gel

PURIFIED CORTROPHIN GEL (Repository Corticotropin Injection USP) Rx only

Approved
Approval ID

f27544ee-a0e2-4d84-b193-1c9efdf9e34c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 25, 2023

Manufacturers
FDA

ANI Pharmaceuticals, Inc.

DUNS: 145588013

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Repository Corticotropin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62559-860
Application NumberNDA008975
Product Classification
M
Marketing Category
C73594
G
Generic Name
Repository Corticotropin
Product Specifications
Route of AdministrationINTRAMUSCULAR, SUBCUTANEOUS
Effective DateJune 21, 2023
FDA Product Classification

INGREDIENTS (6)

CORTICOTROPINActive
Quantity: 80 [USP'U] in 1 mL
Code: K0U68Q2TXA
Classification: ACTIB
GELATIN, UNSPECIFIEDInactive
Code: 2G86QN327L
Classification: IACT
PHENOLInactive
Code: 339NCG44TV
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.